超强的I类中和抗体后Omicron突破感染克服广泛的SARS-CoV-2逃生变体
Mengxiao Luo1, Runhong Zhou2, Bingjie Tang3
1AIDS Institute, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, People's Republic of China; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, People's Republic of China.
新的广泛中和抗体 (bnAbs) 提供了对演变的SARS-CoV-2 Omicron变体如JN.1和KP.2的强有力的保护. 这些发现突出了下一代疫苗和抗体疗法针对COVID-19的潜在目标.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 结构生物学 结构生物学
背景情况:
- 新兴的SARS-CoV-2亚系 (JN.1,KP.2) 推动了全球的COVID-19浪潮.
- 记忆B细胞对抗原漂移的Omicron变体的反应尚未完全理解.
研究的目的:
- 调查人类B细胞免疫力对SARS-CoV-2的进化.
- 发现新型广泛中和抗体 (bnAbs) 对Omicron亚型有效.
主要方法:
- 单个B细胞克隆和目录分析.
- 伪病毒中和试验和冷电子显微镜 (cryo-EM).
- 在金色的叙利亚仓鼠体内疗效研究.
主要成果:
- 从接种疫苗的人群中鉴定出新的I类bnAbs. 在Omicron突破后的感染.
- 两个bnAbs中和了JN.1和KP.2的高强度 (IC50<10 ng/mL).
- BnAbs针对ACE2阻断的受体结合动机 (RBM) 中的保存表位;ZCP3B4保护了仓鼠并阻止了传播.
结论:
- 一级bnAbs证明了对可传播的Omicron逃生变体的超强中和.
- 已识别的表位是新型bnAbs和疫苗开发的有希望的目标.
更多相关视频
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
相关概念视频
Cross-reactivity
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
